Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5126]

ASCO 2016: Current treatment approaches for advanced prostate cancer

Prof Przemyslaw Twardowski and Prof Gordon McVie

ASCO 2016: Current treatment approaches for advanced prostate cancer ( Prof Przemyslaw Twardowski and Prof Gordon McVie )

The value and strategy for incorporating biosimilars Into clinical practice

Dr Francisco Esteva - New York University, New York, USA

The value and strategy for incorporating biosimilars Into clinical practice ( Dr Francisco Esteva - New York University, New York, USA )

Checkpoint inhibitor therapy benefits advanced bladder cancer patients

Dr Arjun Vasant Balar - NYU Langone Medical Center, New York, USA

Checkpoint inhibitor therapy benefits advanced bladder cancer patients ( Dr Arjun Vasant Balar - NYU Langone Medical Center, New York, USA )

Adjuvant docetaxel fails after radical prostatectomy for high risk prostate...

Dr Goran Ahlgren - Lund University, Malmö, Sweden

Adjuvant docetaxel fails after radical prostatectomy for high risk prostate cancer ( Dr Goran Ahlgren - Lund University, Malmö, Sweden )

Sequencing analysis with circulating DNA

Dr Oliver Zill - Guardant Health Inc, Brentwood City, USA

Sequencing analysis with circulating DNA ( Dr Oliver Zill - Guardant Health Inc, Brentwood City, USA )

Targetting PD-L1 with avelumab in metastatic Merkel cell carcinoma

Dr Howard Kaufman - Rutgers Cancer Institute of New Jersey, USA

Targetting PD-L1 with avelumab in metastatic Merkel cell carcinoma ( Dr Howard Kaufman - Rutgers Cancer Institute of New Jersey, USA )

Ten years of letrozole improves survival and quality of life in early-diagnosed...

Dr Julie Lemieux - Hôpital du Saint-Sacrement, Québec, Canada

Ten years of letrozole improves survival and quality of life in early-diagnosed breast cancer. ( Dr Julie Lemieux - Hôpital du Saint-Sacrement, Québec, Canada )

Daratumumab slows progression in refractory multiple myeloma

Prof Palumbo - University of Turin, Turin, Italy

$Daratumumab slows progression in refractory multiple myeloma ( Prof Palumbo - University of Turin, Turin, Italy )$

Developments in haematological malignancies

Dr Stephen Nimer - University of Miami, Miami, USA

Developments in haematological malignancies ( Dr Stephen Nimer - University of Miami, Miami, USA )

Recent developments in targeted therapies

Dr Stephen Nimer - University of Miami, Miami, USA

Recent developments in targeted therapies ( Dr Stephen Nimer - University of Miami, Miami, USA )

First results of a prospective bendamustine/rituximab trial in patients with MCL

Dr Mathias Rummel - University of Giessen, Giessen, Germany

First results of a prospective bendamustine/rituximab trial in patients with MCL ( Dr Mathias Rummel - University of Giessen, Giessen, Germany )

MyPathway guidance of targeted therapy based on molecular profiles

Dr John Hainsworth - Sarah Cannon Research Institute, Nashville, USA

MyPathway guidance of targeted therapy based on molecular profiles ( Dr John Hainsworth - Sarah Cannon Research Institute, Nashville, USA )

More from ecancer